AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Fransson, P Tavelin, B Widmark, A
Citation: P. Fransson et al., Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects, SUPP CARE C, 9(3), 2001, pp. 187-198

Authors: Rydh, A Ahlstrom, KR Widmark, A Johansson, L Nilsson, S Bergh, A Damber, JE Stigbrand, T Hietala, SO
Citation: A. Rydh et al., Radioimmunoscintigraphy using an anti-prostate monoclonal antibody (E4): adosimetric evaluation, UROL RES, 29(3), 2001, pp. 216-220

Authors: Fransson, P Lofroth, PO Franzen, L Henriksson, R Bergstrom, P Widmark, A
Citation: P. Fransson et al., Acute side effects after dose-escalation treatment of prostate cancer using the new urethral catheter BeamCath((R)) technique, ACTA ONCOL, 40(6), 2001, pp. 756-765

Authors: Bylund, A Zhang, JX Bergh, A Damber, JE Widmark, A Johansson, A Adlercreutz, H Aman, P Shepherd, MJ Hallmans, G
Citation: A. Bylund et al., Rye bran and soy protein delay growth and increase apoptosis of human LNCaP prostate adenocarcinoma in nude mice, PROSTATE, 42(4), 2000, pp. 304-314

Authors: Adlercreutz, H Mazur, W Bartels, P Elomaa, VV Watanabe, S Wahala, K Landstrom, M Lundin, E Bergh, A Damber, JE Aman, P Widmark, A Johansson, A Zhang, JX Hallmans, G
Citation: H. Adlercreutz et al., Phytoestrogens and prostate disease, J NUTR, 130(3), 2000, pp. 658S-659S

Authors: Granfors, T Tomic, R Bergh, A Rydh, M Lofroth, PO Widmark, A
Citation: T. Granfors et al., After radiotherapy testosterone stimulation is unable to increase growth in the Dunning R3327-PAP prostate tumour, UROL RES, 27(5), 1999, pp. 357-361

Authors: Rydh, A Riklund-Ahlstrom, K Widmark, A Bergh, A Johansson, L Tavelin, B Nilsson, S Stigbrand, T Damber, JE Hietala, SO
Citation: A. Rydh et al., Radioimmunotherapy of DU-145 tumours in nude mice - A pilot study with E4,a novel monoclonal antibody against prostate cancer, ACTA ONCOL, 38(8), 1999, pp. 1075-1079

Authors: Granfors, T Bergh, A Lofroth, PO Widmark, A
Citation: T. Granfors et al., Fractionated radiotherapy of rat prostatic adenocarcinoma (Dunning R3327-PAP) in nonanesthetized animals, PROSTATE, 39(1), 1999, pp. 16-22

Authors: Fransson, P Widmark, A
Citation: P. Fransson et A. Widmark, Late side effects unchanged 4-8 years after radiotherapy for prostate carcinoma - A comparison with age-matched controls, CANCER, 85(3), 1999, pp. 678-688

Authors: Johansson, M Bergenheim, AT Widmark, A Henriksson, R
Citation: M. Johansson et al., Effects of radiotherapy and estramustine on the microvasculature in malignant glioma, BR J CANC, 80(1-2), 1999, pp. 142-148

Authors: Bylund, A Stattin, P Widmark, A Bergh, A
Citation: A. Bylund et al., Predictive value of bcl-2 immunoreactivity in prostate cancer patients treated with radiotherapy, RADIOTH ONC, 49(2), 1998, pp. 143-148
Risultati: 1-11 |